Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 18.2.2022GALDERMA INTERNATIONAL (GAD)37402CLOBEX (shp 1x125 ml)10.1.2022O
 18.2.2022Vipharm S.A. (VIH-PL-1)89078OLPINAT 10 mg (tbl flm 56x10 mg (blis.OPA/Al/PVC/Al))18.2.2022R
 17.2.2022B.Braun Melsungen AG (BME)1344CNutriflex Omega special 56/144 (emu inf 5x1250 ml (vak infúzny viackomorový))17.2.2022R
 17.2.2022Novartis Europharm Limited (NEH-IE)20584Votrient 400 mg filmom obalené tablety (tbl flm 30x400 mg (fľ.HDPE))18.2.2022O
 16.2.2022CANDE s.r.o. (CRR-SK)5386CALFAMED 1,0 mikrogram (cps mol 90x1 µg (fľ.HDPE s PP uzáver.))28.2.2022R
 16.2.2022Mylan IRE Healthcare Limited (MYR)48200Gopten 2 mg (cps 28x2 mg (blis.PVC/PVDC/Al))21.2.2022R
 16.2.2022KRKA, d.d., Novo mesto (KRK-2)4390CBetaklav 875 mg/125 mg filmom obalené tablety (tbl flm 14x875 mg/125 mg (blis.OPA/Al/PVC/Al))21.2.2022R
 16.2.2022KRKA, d.d., Novo mesto (KRK-2)8567CLamegom 25 mg filmom obalené tablety (tbl flm 98x25 mg (blis.OPA/Al/PVC/Al))21.2.2022O
 16.2.2022Mylan IRE Healthcare Limited (MYR)62402Fraxiparine 7 600 IU (anti Xa)/0,8 ml (sol inj 10x0,8 ml/7,6 KU (striek.inj.skl.napl.))17.2.2022O
 16.2.2022Mylan IRE Healthcare Limited (MYR)97858Fraxiparine 3 800 IU (anti Xa)/0,4 ml (sol inj 10x0,4 ml/3,8 KU (striek.inj.skl.napl.))1.3.2022R
 16.2.2022Ewopharma International, s.r.o. (EWO-SK-2)81327Isoprinosine 500 mg tablety (tbl 100x500 mg (blis. PVC/PVDC/Al))15.2.2022O
 15.2.2022Accord Healthcare Polska Sp. z o.o. (AOK)20362Paclitaxel Accord 6 mg/ml infúzny koncentrát (con inf 1x5 ml/30 mg (liek.inj.skl.))17.2.2022O
 15.2.2022Accord Healthcare S.L.U (ACC-ES)12357Levetiracetam Accord 250 mg filmom obalené tablety (tbl flm 50x250 mg (blis.PVC/Al))16.2.2022O
 15.2.2022Menarini International Operations Luxembourg S.A. (MNR)40032Frovamen (tbl flm 6x2,5 mg (blis.PVC/PE/PVDC/Al))1.3.2022R
 15.2.2022Boehringer Ingelheim International GmbH (BOE)4813BSynjardy 12,5 mg/850 mg filmom obalené tablety (tbl flm 60x1x12,5 mg/850 mg (blis.PVC/PVDC/Al-perf.))15.3.2022Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)